Blue Cross of Idaho Logo

Express Sign-on

Thank you for registering with Blue Cross of Idaho

If you are an Individual or Family Member under age 65, please register here.

If you are an Medicare or Medicare Supplement member, please register here.

New Options for Affordable Health Insurance

Medical Policies

5.0 Prescription Drug

5
5.01 Prescription Drugs Introduction
Medically
Necessary
and
Investigational
For Blue Cross of Idaho`s definition of medically necessary and investigational, please click here.
5.01.01 Guidelines for Prior Authorization of Pharmacologic Therapies
5.01.04 Erythropoiesis- Stimulating Agents (ESAs)
5.01.05 Botulinum Toxin
5.01.06 Human Growth Hormone
5.01.07 Acute and Maintenance Tocolysis
5.01.08 Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease
5.01.09 Advanced Therapies for Pharmacological Treatment of Pulmonary Arterial Hypertension
5.01.10 Immune Prophylaxis for Respiratory Syncytial Virus
5.01.12 Trastuzumab
5.01.15 Uses of Infliximab
5.01.16 Intravenous Anesthetics for the Treatment of Chronic Pain
5.01.17 Repository Corticotropin Injection
5.01.18 Bevacizumab in Advanced Adenocarcinoma of the Pancreas
5.01.19 Injectable Clostridial Collagenase for Firbroproliferative Disorders 
5.01.21 Newer Oral Anticoagulants
5.01.22 Ado-Trastuzumab Emtansine (Trastuzumab-DM1) for Treatment of HER-2 Positive Malignancies
5.01.23 Testosterone Replacement Therapies
5.01.25 Direct Acting Antiviral Medications for Treatment of Hepatitis C
5.01.93 Specialty Drugs
5.01.95 Xolair (Omalizumab)
5.01.96 Therapeutically Generic Override
5.01.97 Tysabri (natalizumab)
5.01.99 Treatment of Arthropathies with Biologic-Response Modifiers
5.01.100 Treatment of Inflammatory Bowel Diseases with Biologic-Response Modifiers
5.01.101 Enzyme-replacement Therapy for Lysosomal Storage Disorders
5.01.102 Sunitinib (Sutent®)
5.01.105 IV Iron Therapy
5.01.108 Pharmacological Treatment of Hereditary Angioedema
5.01.109 Implantable Hormone Pellets
5.01.110 Belimumab (Benlysta®)
5.01.111 Eculizumab (Soliris)
5.01.112 Use of Sodium Oxybate (Xyrem®)
5.01.150 Pharmacologic Compounds